Thomas Trimarchi
President and CFO · 3 filings · Latest: May 16, 2026
BridgeBio Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BBIO | Thomas Trimarchi | President and CFO | May 18, 2026 | Sale | $65.08 | 13,651 | $888.4K | 359,194 | |
BBIO | THOMAS TRIMARCHI | — | May 18, 2026 | Proposed Sale | $65.08 | 13,651 | $888.4K | — | |
BBIO | Thomas Trimarchi | President and CFO | Feb 17, 2026 | Sale | $74.72 | 13,600 | $1.0M | 336,585 | |
BBIO | THOMAS TRIMARCHI | — | Feb 17, 2026 | Proposed Sale | $74.72 | 13,600 | $1.0M | — | |
BBIO | THOMAS TRIMARCHI | — | Nov 17, 2025 | Proposed Sale | $66.46 | 16,934 | $1.1M | — | |
BBIO | THOMAS TRIMARCHI | — | Aug 21, 2025 | Proposed Sale | $49.48 | 42,237 | $2.1M | — | |
BBIO | THOMAS TRIMARCHI | — | Aug 18, 2025 | Proposed Sale | $50.23 | 17,353 | $871.7K | — |